Janney Montgomery Scott LLC Raises Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Janney Montgomery Scott LLC raised its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 210.5% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 64,191 shares of the medical instruments supplier's stock after acquiring an additional 43,516 shares during the period. Janney Montgomery Scott LLC's holdings in DENTSPLY SIRONA were worth $959,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in XRAY. Treasurer of the State of North Carolina lifted its position in DENTSPLY SIRONA by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock valued at $1,686,000 after purchasing an additional 560 shares during the period. Quarry LP raised its stake in DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock valued at $72,000 after buying an additional 780 shares during the last quarter. Federated Hermes Inc. raised its stake in DENTSPLY SIRONA by 0.5% during the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock valued at $3,213,000 after buying an additional 915 shares during the last quarter. Covestor Ltd lifted its holdings in shares of DENTSPLY SIRONA by 14.9% during the 4th quarter. Covestor Ltd now owns 8,322 shares of the medical instruments supplier's stock valued at $158,000 after buying an additional 1,081 shares during the period. Finally, Colonial Trust Co SC purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter worth $26,000. Hedge funds and other institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $15.93 on Monday. The company has a market capitalization of $3.17 billion, a P/E ratio of -3.51, a P/E/G ratio of 1.14 and a beta of 0.95. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $27.95. The firm's 50 day simple moving average is $15.39 and its two-hundred day simple moving average is $16.55. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.10 and a quick ratio of 0.76.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The company had revenue of $879.00 million for the quarter, compared to analysts' expectations of $854.75 million. During the same quarter in the previous year, the company earned $0.42 EPS. DENTSPLY SIRONA's revenue for the quarter was down 7.8% on a year-over-year basis. Research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.02%. The ex-dividend date of this dividend is Friday, June 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.10%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on XRAY shares. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Piper Sandler dropped their target price on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 30th. Barrington Research boosted their price target on DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a research note on Monday, May 12th. UBS Group reduced their price target on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Finally, Wall Street Zen upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Eleven investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $20.36.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.